scholarly article | Q13442814 |
P356 | DOI | 10.1007/S10620-015-3734-5 |
P698 | PubMed publication ID | 26048020 |
P2093 | author name string | Lei Zhao | |
Shan Huang | |||
Zhigang Chen | |||
Guobin Wu | |||
Jiye Zhu | |||
Chaoyuan Huang | |||
Yinnong Zhao | |||
Xianjian Li | |||
P2860 | cites work | Global cancer statistics | Q22241238 |
The Hallmarks of Cancer | Q221226 | ||
Management of hepatocellular carcinoma: An update | Q27860530 | ||
Lysyl oxidase: properties, specificity, and biological roles inside and outside of the cell | Q28208372 | ||
Lysyl oxidase: a lung adenocarcinoma biomarker of invasion and survival | Q28236372 | ||
RETRACTED: Lysyl oxidase is essential for hypoxia-induced metastasis | Q28236828 | ||
Lysyl oxidase plays a critical role in endothelial cell stimulation to drive tumor angiogenesis | Q28280138 | ||
The role of lysyl oxidase in SRC-dependent proliferation and metastasis of colorectal cancer | Q28304399 | ||
Tumor metastasis: mechanistic insights and clinical challenges | Q29617676 | ||
Lysyl oxidase expression and inhibition in uveal melanoma | Q33533735 | ||
Retinoic acid is a cofactor for translational regulation of vascular endothelial growth factor in human endometrial stromal cells | Q33576463 | ||
Cathepsin G-mediated enhanced TGF-beta signaling promotes angiogenesis via upregulation of VEGF and MCP-1. | Q33625023 | ||
Lysyl oxidase-related protein-1 promotes tumor fibrosis and tumor progression in vivo | Q34187677 | ||
Lysyl oxidase: from basic science to future cancer treatment | Q34263983 | ||
Lysyl oxidase contributes to mechanotransduction-mediated regulation of transforming growth factor-β signaling in breast cancer cells | Q34887552 | ||
Lysyl oxidase secreted by tumour endothelial cells promotes angiogenesis and metastasis | Q37235503 | ||
Vascular endothelial growth factor in the management of hepatocellular carcinoma: a review of literature | Q37564297 | ||
Molecular pathogenesis of hepatocellular carcinoma: altering transforming growth factor-β signaling in hepatocarcinogenesis | Q37914625 | ||
Transforming growth factor-β as a therapeutic target in hepatocellular carcinoma | Q38196739 | ||
Angiogenesis in cancer - general pathways and their therapeutic implications | Q38198596 | ||
Differential regulation of TGF-β-induced, ALK-5-mediated VEGF release by SMAD2/3 versus SMAD1/5/8 signaling in glioblastoma | Q38962204 | ||
Lysyl oxidase-like 2 is critical to tumor microenvironment and metastatic niche formation in hepatocellular carcinoma. | Q38973071 | ||
Intracellular lysyl oxidase: effect of a specific inhibitor on nuclear mass in proliferating cells | Q42163130 | ||
TGF-β1 induces endothelial cell apoptosis by shifting VEGF activation of p38(MAPK) from the prosurvival p38β to proapoptotic p38α. | Q42175314 | ||
Expression of lysyl oxidase in human osteosarcoma and its clinical significance: a tumor suppressive role of LOX in human osteosarcoma cells | Q43804532 | ||
Increasing matrix stiffness upregulates vascular endothelial growth factor expression in hepatocellular carcinoma cells mediated by integrin β1. | Q44711049 | ||
Matrix GLA protein stimulates VEGF expression through increased transforming growth factor-beta1 activity in endothelial cells | Q46172310 | ||
Members of the lysyl oxidase family are expressed during the development of the frog Xenopus laevis | Q46826619 | ||
Lysyl oxidase regulates breast cancer cell migration and adhesion through a hydrogen peroxide-mediated mechanism | Q46853176 | ||
Expression of the lysyl oxidase propeptide in hepatocellular carcinoma and its clinical relevance | Q47907123 | ||
Induction of cardiac fibroblast lysyl oxidase by TGF-β1 requires PI3K/Akt, Smad3, and MAPK signaling. | Q54596208 | ||
Lysyl Oxidase Activates the Transcription Activity of Human Collagene III Promoter | Q58620548 | ||
Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies | Q73490475 | ||
Quantitative analysis of vascular endothelial growth factor, microvascular density and their clinicopathologic features in human hepatocellular carcinoma | Q81771446 | ||
The role of Twist1 in hepatocellular carcinoma angiogenesis: a clinical study | Q83134326 | ||
[Mechanism of lysyl oxidase (LOX) in breast cancer invasion and metastasis] | Q84773371 | ||
P433 | issue | 10 | |
P921 | main subject | endothelium | Q111140 |
P304 | page(s) | 3019-3031 | |
P577 | publication date | 2015-06-06 | |
P1433 | published in | Digestive Diseases and Sciences | Q15716711 |
P1476 | title | Lysyl Oxidase Is Predictive of Unfavorable Outcomes and Essential for Regulation of Vascular Endothelial Growth Factor in Hepatocellular Carcinoma | |
P478 | volume | 60 |
Q38813691 | Advanced glycation end products upregulate lysyl oxidase and endothelin-1 in human aortic endothelial cells via parallel activation of ERK1/2-NF-κB and JNK-AP-1 signaling pathways |
Q58764034 | Inhibition of lysyl oxidase expression by dextran sulfate affects invasion and migration of gastric cancer cells |
Q90625330 | Lysyl oxidase impacts disease outcomes and correlates with global DNA hypomethylation in esophageal cancer |
Q92666152 | Lysyl oxidase induces epithelial-mesenchymal transition and predicts intrahepatic metastasis of hepatocellular carcinoma |
Q28068373 | The role of integrins in TGFβ activation in the tumour stroma |
Q92714751 | Under-expression of LKB1 is associated with enhanced p38-MAPK signaling in human hepatocellular carcinoma |
Search more.